Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Concentration of ciprofloxacin in human serum, lung and pleural tissues and fluids during and after lung surgery.

Literature DB >> 3360495

Concentration of ciprofloxacin in human serum, lung and pleural tissues and fluids during and after lung surgery.

G Hopf¹, R Böcker, C J Estler, H J Radtke, W Floh.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：
Ciprofloxacin

Year: 1988 PMID： 3360495 DOI： 10.1007/bf01646928

Source DB: PubMed Journal: Infection ISSN： 0300-8126 Impact factor: 3.553

× No keyword cloud information.

8 in total

1. Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration.

Authors: K Borner; G Höffken; H Lode; P Koeppe; C Prinzing; P Glatzel; R Wiley; P Olschewski; B Sievers; D Reinitz
Journal: Eur J Clin Microbiol Date: 1986-04 Impact factor: 3.267

2. Determination of ciprofloxacin in biological samples by reversed-phase high performance liquid chromatography.

Authors: F Vallée; M LeBel; M G Bergeron
Journal: Ther Drug Monit Date: 1986 Impact factor: 3.681

3. Penetration of ciprofloxacin into human lung tissue following intravenous injection.

Authors: D Schlenkhoff; A Dalhoff; J Knopf; W Opferkuch
Journal: Infection Date: 1986 Nov-Dec Impact factor: 3.553

4. Dose ranging study and constant infusion evaluation of ciprofloxacin.

Authors: G L Drusano; K I Plaisance; A Forrest; H C Standiford
Journal: Antimicrob Agents Chemother Date: 1986-09 Impact factor: 5.191

5. Antibacterial activity of the metabolites of ciprofloxacin and its significance in the bioassay.

Authors: H J Zeiler; U Petersen; W Gau; H J Ploschke
Journal: Arzneimittelforschung Date: 1987-02

6. [Biotransformation of selected gyrase inhibitors].

Authors: K Borner; H Lode
Journal: Infection Date: 1986 Impact factor: 3.553

7. The in vitro and in vivo activity of ciprofloxacin.

Authors: H J Zeiler; K Grohe
Journal: Eur J Clin Microbiol Date: 1984-08 Impact factor: 3.267

8. [A cross-over study on the effectiveness of ofloxacin and ciprofloxacin administered orally].

Authors: C C Kurz; W Marget; K Harms; R M Bertele
Journal: Infection Date: 1986 Impact factor: 3.553

8 in total

10 in total

Review 1. Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials.

Authors: A Aminimanizani; P Beringer; R Jelliffe
Journal: Clin Pharmacokinet Date: 2001 Impact factor: 6.447

2. The penetration of ciprofloxacin into bronchial mucosa, lung parenchyma, and pleural tissue after intravenous administration.

Authors: M Dan; K Torossian; D Weissberg; R Kitzes
Journal: Eur J Clin Pharmacol Date: 1993 Impact factor: 2.953

3. Ciprofloxacin penetration into the pulmonary parenchyma in Japanese patients.

Authors: Shuji Haraguchi; Masafumi Hioki; Koji Yamashita; Koan Orii; Yasuo Yamashita; Jun Kawamura; Mina Takushima; Naoya Endo; Kiyoshi Koizumi; Kazuo Shimizu
Journal: Surg Today Date: 2007-03-26 Impact factor: 2.549

4. Possible interaction of fluoroquinolones with the benzodiazepine-GABAA-receptor complex.

Authors: E Unseld; G Ziegler; A Gemeinhardt; U Janssen; U Klotz
Journal: Br J Clin Pharmacol Date: 1990-07 Impact factor: 4.335

5. Penetration of ciprofloxacin into bronchial secretions from mechanically ventilated patients with nosocomial bronchopneumonia.

Authors: P Saux; C Martin; M N Mallet; L Papazian; B Bruguerolle; P De Micco; F Gouin
Journal: Antimicrob Agents Chemother Date: 1994-04 Impact factor: 5.191